| Literature DB >> 33892622 |
Reymundo Lozano1,2,3,4, Catherine Gbekie5, Paige M Siper6,7, Shubhika Srivastava8, Jeffrey M Saland8,9, Swathi Sethuram8, Lara Tang5,6, Elodie Drapeau5,6, Yitzchak Frank6,7, Joseph D Buxbaum5,6,7,10,11, Alexander Kolevzon6,7,8,10,11.
Abstract
FOXP1 syndrome is a neurodevelopmental disorder caused by mutations or deletions that disrupt the forkhead box protein 1 (FOXP1) gene, which encodes a transcription factor important for the early development of many organ systems, including the brain. Numerous clinical studies have elucidated the role of FOXP1 in neurodevelopment and have characterized a phenotype. FOXP1 syndrome is associated with intellectual disability, language deficits, autism spectrum disorder, hypotonia, and congenital anomalies, including mild dysmorphic features, and brain, cardiac, and urogenital abnormalities. Here, we present a review of human studies summarizing the clinical features of individuals with FOXP1 syndrome and enlist a multidisciplinary group of clinicians (pediatrics, genetics, psychiatry, neurology, cardiology, endocrinology, nephrology, and psychology) to provide recommendations for the assessment of FOXP1 syndrome.Entities:
Keywords: ASD; Autism spectrum disorder; FOXP1; FOXP1 syndrome; Forkhead box protein 1
Year: 2021 PMID: 33892622 DOI: 10.1186/s11689-021-09358-1
Source DB: PubMed Journal: J Neurodev Disord ISSN: 1866-1947 Impact factor: 4.025